[1]
Abdul Malik et al. 2026. Beyond Glycaemic Control: The Expanding Role of GLP-1 Receptor Agonists in Obesity, Obstructive Sleep Apnoea, Cardiovascular Disease, and Steatohepatitis: A Narrative Review. Journal of Health, Wellness and Community Research. 4, 11 (Jun. 2026), 1–12. DOI:https://doi.org/10.61919/7n09x564.